Clinical Re-evaluation of Removing Blood Stasis Therapy in Treating Acute Cerebral Hemorrhage Safety and Efficacy

A phase 4 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 360 participants.

Also called NCT01918722

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; quadruple masking; primary purpose treatment
Phase
Phase 4
Enrolled
  • 360 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT01918722
Other papers using this trial's data
  • Safety and efficacy of herbal medicine for acute intracerebral hemorrhage (CRRICH): a multicentre randomised controlled trial BMJ open, 2019-05-09 DOI, PubMed 31076468, PMC6528012 In the PMC Open Access subset under CC BY-NC.

Courtesy of the U.S. National Library of Medicine.

Start date
(registry gives no type) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
China (from the registry)
Registry status
  • Unknown status (from the registry)

Technical summary

Registry record NCT01918722. Randomized; quadruple masking; primary purpose treatment. Start 2013-10 (registry gives no type); primary completion 2016-06 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Clinical Re-evaluation of Removing Blood Stasis Therapy in Treating Acute Cerebral Hemorrhage Safety and Efficacy
Condition
Intracerebral Hemorrhage
Intervention (Drug)
ICH-1(herbal medicine with Hirudo, Tabanus)
Intervention (Drug)
placebo
Intervention (Drug)
ICH-2(herbal medicine without Hirudo, Tabanus)
Lead sponsor
Guangzhou University of Traditional Chinese Medicine (class: other)

Record details

Record id
cardio:ct-nct01918722
Content hash
b793a7b7f2557608d2d2772e0ee1151f5edcdbab24156392040f30d47f5a606d